Results 171 to 180 of about 585,525 (398)

Multiomics insight into the role of glucagon‐like peptide‐1 receptor agonists in heart failure

ESC Heart Failure, EarlyView.
Graphical abstract of the multiomics insight into the role of GLP1Ra in cardiovascular diseases and the underlying pathway. GLP1Ra, glucagon‐like peptide‐1 receptor agonist. Abstract Aims Cardiovascular diseases, such as atrial fibrillation, coronary artery disease, heart failure (HF) and ischaemic stroke, are leading causes of death globally and exert
Yuhang Tao, Qi Liu, Yuxing Wang, Yingchao Gong, Mingying Xu, Ruhong Jiang, Kai Zhang   +6 more
wiley   +1 more source

Quantification of Trabeculae Inside the Heart from MRI Using Fractal Analysis [PDF]

arXiv, 2018
Left ventricular non-compaction (LVNC) is a rare cardiomyopathy (CMP) that should be considered as a possible diagnosis because of its potential complications which are heart failure, ventricular arrhythmias, and embolic events. For analysis cardiac functionality, extracting information from the Left ventricular (LV) is already a broad field of Medical
arxiv  

ASB1 differential methylation in ischaemic cardiomyopathy. Relationship with left ventricular performance in end stage heart failure patients [PDF]

arXiv, 2017
Aims: Ischaemic cardiomyopathy (ICM) leads to impaired contraction and ventricular dysfunction causing high rates of morbidity and mortality. Epigenomics allows the identification of epigenetic signatures in human diseases. We analyse the differential epigenetic patterns of ASB gene family in ICM patients and relate these alterations to their ...
arxiv  

Left Ventricular Hypertrophy

Developments in Cardiovascular Medicine, 2020
E. E. Wall, A. Laarse, B. Pluim, AlbertV.G. Bruschke   +3 more
semanticscholar   +1 more source

Vectorcardiographic evolution of left ventricular hypertrophy. [PDF]

, 1968
Hubert Bell, David Pugh, Marvin Dunn
openalex   +1 more source

Association of baseline and longitudinal changes in insulin‐like growth factor‐binding protein‐7 with the risk of incident heart failure: Data from the PREVEND study

European Journal of Heart Failure, EarlyView.
Insulin‐like growth factor‐binding protein‐7 (IGFBP7) and heart failure (HF) risk: the PREVEND study. CI, confidence interval; HR, hazard ratio. Abstract Aim Senescence is a major risk factor for heart failure (HF), and insulin‐like growth factor‐binding protein‐7 (IGFBP7) has been identified as an important senescence‐inducing factor.
Sabrina Abou Kamar, Valentina Bracun, Maissa El‐Qendouci, Nils Bomer, Stephan J.L. Bakker, Ron T. Gansevoort, Eric Boersma, Isabella Kardys, Rudolf A. de Boer, Navin Suthahar   +9 more
wiley   +1 more source

The Mayo ATTR‐CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis

European Journal of Heart Failure, EarlyView.
Proposed algorithm to screen for transthyretin cardiac amyloidosis (ATTR‐CA). AL‐CA, immunoglobulin light‐chain cardiac amyloidosis; AMYLI, AMYLoidosis Index; AUC, area under the curve; IWT, increased wall thickness; LVEF, left ventricular ejection fraction; PYP, pyrophosphate.
Giovanni Battista Bonfioli, Daniela Tomasoni, Giuseppe Vergaro, Vincenzo Castiglione, Marianna Adamo, Iacopo Fabiani, Victor Loghin, Carlo Mario Lombardi, Alessio Nicolai, Marco Metra, Michele Emdin, Alberto Aimo   +11 more
wiley   +1 more source

The T-V ₁ >T-V ₆ Pattern for Electrocardiographic Diagnosis of Left Ventricular Hypertrophy and Ischemia [PDF]

, 1965
Noboru Okamoto, Ernst Simonson, Henry Blackburn   +2 more
openalex   +1 more source

Microvascular obstruction in cardiac amyloidosis

European Journal of Heart Failure, EarlyView.
Abstract Aims Cardiac amyloidosis (CA) is characterized by deposition of amyloid fibrils within the extracellular space, causing disarray of the myocardial structure and capillary architecture. This study aims to characterize the prevalence of microvascular obstruction (MVO) in patients with CA and to assess the association between MVO and prognosis ...
Lucrezia Netti, Adam Ioannou, Ana Martinez‐Naharro, Yousuf Razvi, Aldostefano Porcari, Lucia Venneri, Viviana Maestrini, Dan Knight, Ruta Virsinskaite, Muhammad U. Rauf, Tushar Kotecha, Rishi K. Patel, Ashutosh Wechelakar, Helen Lachmann, Peter Kellman, Charlotte Manisty, James Moon, Philip N. Hawkins, Julian D. Gillmore, Marianna Fontana   +19 more
wiley   +1 more source

The efficacy of PDE5 inhibitors in diabetic patients

Andrology, Volume 11, Issue 2, Page 245-256, February 2023., 2023
Abstract Background Phosphodiesterase 5 inhibitors (PDE5i), since their introduction in the late 1990s, have proven their efficacy in treating several conditions, predominantly pulmonary hypertension and erectile dysfunction where they remain the first‐line therapeutic option.
Agnieszka Swiecicka
wiley   +1 more source